• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.

作者信息

Edmonson J H, Fleming T R, Decker D G, Jorgensen E O, Malkasian G D, Jefferies J A, Kvols L K, Webb M J

出版信息

Recent Results Cancer Res. 1978;68:157-9. doi: 10.1007/978-3-642-81332-0_23.

DOI:10.1007/978-3-642-81332-0_23
PMID:752853
Abstract
摘要

相似文献

1
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.卵巢癌手术切除后微小残留病的化疗敏感性
Recent Results Cancer Res. 1978;68:157-9. doi: 10.1007/978-3-642-81332-0_23.
2
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.
Cancer Treat Rep. 1979 Feb;63(2):241-7.
3
Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.阿霉素-环磷酰胺±卡介苗用于晚期卵巢癌的化学免疫疗法：西南肿瘤协作组研究的早期报告
Recent Results Cancer Res. 1978;68:160-5. doi: 10.1007/978-3-642-81332-0_24.
4
[Chemotherapic management of genitomammary tumors].[泌尿生殖系统肿瘤的化疗管理]
Rev Fac Cien Med Univ Nac Cordoba. 1981 Jan-Dec;39(1-4):3-16.
5
Pharmacokinetics of intraperitoneal doxorubicin in combination with systemic cyclophosphamide and cis-platinum in the treatment of stage III ovarian cancer.腹腔内注射阿霉素联合全身应用环磷酰胺和顺铂治疗Ⅲ期卵巢癌的药代动力学
Gynecol Oncol. 1990 Feb;36(2):185-8. doi: 10.1016/0090-8258(90)90170-p.
6
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
Clin Obstet Gynaecol. 1983 Aug;10(2):307-24.
7
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.贝伐单抗联合每周紫杉醇、聚乙二醇化脂质体阿霉素或拓扑替康用于铂耐药复发性卵巢癌：随机III期AURELIA试验化疗队列分析
J Clin Oncol. 2015 Nov 10;33(32):3836-8. doi: 10.1200/JCO.2015.63.1408. Epub 2015 Aug 17.
8
[Progress in the chemotherapy of ovarian cancer].
Wien Med Wochenschr. 1982 Jul 31;132(13-14):319-24.
9
Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.阿霉素单独使用、阿霉素加长春新碱、阿霉素加环磷酰胺治疗晚期宫颈癌的疗效比较。
Cancer Treat Rep. 1978 Oct;62(10):1435-41.
10
Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.干预性手术在III-IV期上皮性卵巢癌中的作用。
Prog Clin Biol Res. 1985;201:213-5.

引用本文的文献

1
Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma.胃肠道癌患者外周静脉血中CK-20阳性细胞的预后影响
World J Surg. 2005 Apr;29(4):422-8. doi: 10.1007/s00268-004-7662-3.